ResearcherNanjing University of Chinese MedicineActive in the last 2 years
Ming Zhao
Matched on ORCID iD 0000-0001-5912-6108; OpenAlex author ID A5077185494. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. Last author DOI 10.1016/j.phymed.2025.157665↗
- A New C22-Quassinoid with Anti-Pancreatic Adenocarcinoma Activity from Seeds of Brucea javanica. Last author DOI 10.1002/cbdv.202101004↗
- Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer via Nrf2-Mediated Stress-Defense Pathway Suppression and Ferroptosis Induction. Last author DOI 10.1021/acsami.1c22861↗
- A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. Last author DOI 10.1016/j.csbj.2021.06.011↗
- Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer. Last author DOI 10.1016/j.phrs.2021.105658↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weiwei Tao · 4 shared papers, 2021–2026 · strength 0.70
- Paper Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. DOI 10.1016/j.phymed.2025.157665↗
- Paper Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer via Nrf2-Mediated Stress-Defense Pathway Suppression and Fe… DOI 10.1021/acsami.1c22861↗
- Paper A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. DOI 10.1016/j.csbj.2021.06.011↗
- Lu Cai · 4 shared papers, 2021–2026 · strength 0.70
- Paper Bruceine A abrogates pancreatic cancer metastasis by suppressing PFKFB4-glycolysis-EMT axis. DOI 10.1016/j.phymed.2025.157665↗
- Paper Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer via Nrf2-Mediated Stress-Defense Pathway Suppression and Fe… DOI 10.1021/acsami.1c22861↗
- Paper A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. DOI 10.1016/j.csbj.2021.06.011↗
- Si‐Nan Lu · 2 shared papers, 2022–2026 · strength 0.48
- Pengfei Zhang · 3 shared papers, 2021–2022 · strength 0.39
- Paper Enhanced ROS-Boosted Phototherapy against Pancreatic Cancer via Nrf2-Mediated Stress-Defense Pathway Suppression and Fe… DOI 10.1021/acsami.1c22861↗
- Paper A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. DOI 10.1016/j.csbj.2021.06.011↗
- Paper Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer. DOI 10.1016/j.phrs.2021.105658↗
- Wei Liu · 1 shared paper, 2026 · strength 0.32
- Chengbin Yang · 2 shared papers, 2021 · strength 0.25
- Cheng‐Bin Yang · 1 shared paper, 2022 · strength 0.16
- Mingming Xu · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.